Patients not patents: Drug research and development as a public enterprise

Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review

(2017) Peter C Gøtzsche et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Busting the billion-dollar myth: how to slash the cost of drug development

(2016) Amy Maxmen   NATURE

The European Medicines Agency is still too close to industry:

(2016) Silvio Garattini   BMJ-British Medical Journal

“Adaptive pathways” to drug authorisation: adapting to industry?

(2016) Courtney Davis et al.   BMJ-British Medical Journal

Cancer drugs, survival, and ethics

(2016) Peter H Wise   BMJ-British Medical Journal

The European Medicines Agency is still too close to industry:

(2016) Silvio Garattini   BMJ-British Medical Journal

“Adaptive pathways” to drug authorisation: adapting to industry?

(2016) Courtney Davis et al.   BMJ-British Medical Journal

Cancer drugs, survival, and ethics

(2016) Peter H Wise   BMJ-British Medical Journal

Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy

(2015) Joel Lexchin   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Approvals of drugs with uncertain benefit–risk profiles in Europe

(2015) Rita Banzi et al.   European Journal of Internal Medicine

Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival

(2015) Chul Kim et al.   JAMA Internal Medicine

‘Choosing Wisely’: a growing international campaign

(2015) Wendy Levinson et al.   BMJ Quality & Safety

Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals

(2014) Cassie Frank et al.   HEALTH AFFAIRS

Effects of 7 days on an ad libitum low-fat vegan diet: the McDougall Program cohort

(2014) John McDougall et al.   Nutrition Journal

Should patient groups be more transparent about their funding?

(2014) S. Arie et al.   BMJ-British Medical Journal

Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

(2014) Tito Fojo et al.   JAMA Otolaryngology-Head & Neck Surgery

A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care

(2013) John T. James   Journal of Patient Safety

Surrogate Outcomes in Clinical Trials

(2013) Staffan Svensson et al.   JAMA Internal Medicine

Pharmaceutical research and development: what do we get for all that money?

(2012) D. W. Light et al.   BMJ-British Medical Journal

Open letter to UK Prime Minister David Cameron and Health Secretary Andrew Lansley on safety of medicines

(2011) Kathy Archibald et al.   LANCET

The Role of Public-Sector Research in the Discovery of Drugs and Vaccines

(2011) Ashley J. Stevens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temporal Trends in Rates of Patient Harm Resulting from Medical Care

(2010) Christopher P. Landrigan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Feasibility and challenges of independent research on drugs: the Italian Medicines Agency (AIFA) experience

(2009)   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Drug-Review Deadlines and Safety Problems

(2008) Daniel Carpenter et al.   NEW ENGLAND JOURNAL OF MEDICINE